New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

IBBvsXBIETF Comparison

ETF 1
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
-1.61%
VS
ETF 2
XBI

State Street SPDR S&P Biotech ETF

This fund is part of
US Health Care
-1.61%

iShares Biotechnology ETF (IBB) and State Street SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. IBB's top 3 sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. In contrast, XBI's top sector exposures are Healthcare and Finance. IBB is more expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.35% for XBI. IBB is up 21.8% year-to-date (YTD) with +$837M in YTD flows. XBI performs worse with 19.02% YTD performance, and +$576M in YTD flows. Run a side-by-side ETF comparison of IBB and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBB vs XBI performance and flow charts

Performance

-2.00.02.04.06.08.0%Oct 19Oct 26Nov 2Nov 9Nov 16

Cumulative Flows

-300 M-200 M-100 M0 M100 M200 MOct 19Oct 26Nov 2Nov 9Nov 16

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/18/2026
1M3MYTD1Y3Y5Y
Perf.
IBB
XBI
+0.67%-1.89%
+0.92%-9.38%
+21.80%+19.02%
+23.67%+26.42%
+73.97%+98.50%
+35.36%+19.36%
Flows
IBB
XBI
+$240M-$176M
+$694M-$21M
+$837M+$576M
+$1.60B+$531M
+$353M-$845M
-$794M+$1.12B
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBB
XBI
+28.83%+34.79%
+23.60%+30.24%
+21.63%+28.35%
+22.75%+33.24%
Max drawdown
IBB
XBI
-7.78%-14.89%
-9.61%-14.89%
-24.82%-32.94%
-32.04%-48.67%
Max drawdown duration
IBB
XBI
70d91d
151d91d
377d331d
1418d1468d
Trading data

Create an account to view trading data

Join for free
IBB
XBI
Last sale
11/19/2026 at 2:30 PM
$203.67
$144.05
Previous close
11/18/2026
$205.39
$145.04
Consolidated volume
11/18/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBB
XBI
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/19/2026 at 2:30 PM
Live
Closed
IBB
XBI
Last price
$203.67
$144.05
1D performance
-0.84%
-0.68%
AuM$10.93 B$9.75 B
E/R0.44%0.35%
Characteristics
IBB
XBI
Management strategyPassivePassive
ProvideriSharesState Street Investment Management
BenchmarkNYSE Biotechnology IndexS&P Biotechnology Select Industry Index
N° of holdings235159
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateFebruary 5, 2001January 31, 2006
ESGNoNo
Advertisement
Exposure

Countries

IBB
USA
86.37%
Other
13.63%
XBI
USA
95.32%
Other
4.68%

Sectors

IBB
Healthcare
99.85%
Other
0.15%
XBI
Healthcare
99.16%
Other
0.84%
Advertisement

Diversification

IBB

Total weight of top 15 holdings out of 15

58.82%
XBI

Total weight of top 15 holdings out of 15

24.01%

Top 15 holdings

Data as of September 30, 2026
IBB
Gilead Sciences, Inc.
8.08%
Amgen, Inc.
7.78%
Vertex Pharmaceuticals, Inc.
7.62%
Regeneron Pharmaceuticals, Inc.
5.28%
Moderna, Inc.
4.94%
Natera, Inc.
3.91%
argenx SE
3.74%
Illumina, Inc.
2.89%
Revolution Medicines, Inc.
2.78%
Biogen, Inc.
2.33%
Alnylam Pharmaceuticals, Inc.
2.31%
BeOne Medicines Ltd.
2.16%
Insmed, Inc.
1.72%
Incyte Corp.
1.71%
United Therapeutics Corp.
1.58%
XBI
Twist Bioscience Corp.
2.21%
Moderna, Inc.
2.04%
Natera, Inc.
1.80%
Iovance Biotherapeutics, Inc.
1.62%
Amgen, Inc.
1.55%
Biogen, Inc.
1.54%
United Therapeutics Corp.
1.54%
AbbVie, Inc.
1.50%
Halozyme Therapeutics, Inc.
1.48%
Spyre Therapeutics, Inc.
1.47%
Gilead Sciences, Inc.
1.47%
TG Therapeutics, Inc.
1.47%
CRISPR Therapeutics AG
1.46%
Vertex Pharmaceuticals, Inc.
1.44%
Exelixis, Inc.
1.44%
Frequently asked questions about IBB and XBI

How have the IBB and XBI ETFs performed in 2026?

As of November 18, 2026, IBB is up 21.8% year-to-date (YTD), while XBI has returned 19.02%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: IBB or XBI?

Year-to-date, the IBB ETF saw +$837M in flows, compared to +$576M for XBI.

Which ETF is more volatile: IBB or XBI?

Over the past year, IBB had a volatility of 23.6%, while XBI experienced 30.24%.

Which ETF is bigger: IBB or XBI?

As of November 18, 2026, IBB holds $10.93 B in assets under management (AUM), while XBI manages $9.75 B.

What sectors do the IBB and XBI ETFs invest in?

IBB leans toward sectors like Healthcare. Meanwhile, XBI focuses on Healthcare.

What are the top holdings of the IBB ETF and XBI ETF?

IBB top holdings include Gilead Sciences, Inc., Amgen, Inc. and Vertex Pharmaceuticals, Inc.. XBI holds in its top three: Twist Bioscience Corp., Moderna, Inc. and Natera, Inc..

Which ETF is more diversified: IBB or XBI?

IBB holds 237 securities with 58.82% of its assets in the top 15. XBI has 162 securities and a top 15 weight of 24.01%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026